Exclusive

Publication

Byline

Location

Gavi, UNICEF Cut GSK Mosquirix Vaccine Price By 40%

India, Oct. 22 -- Gavi and UNICEF have reached an agreement to reduce the price of the RTS,S/AS01 malaria vaccine, marketed as Mosquirix, by about 40%, a move expected to save approximately $50 millio... Read More


NurExone Biologic Demonstrates Scalable Exosome Production With Two Bioreactors

India, Oct. 22 -- NurExone Biologic (NRX.V, NRXBF) announced that it doubled exosome production by operating two bioreactors in parallel without increasing overall manufacturing time. The process main... Read More


Eurozone Consumer Confidence Sinks To 5-Month Low Amid Widespread Unrest Against Inflation

India, Oct. 22 -- Euro area consumer sentiment eroded at a faster-than-expected pace in October to reach its lowest level in five months as several countries witness public unrest against a host of is... Read More


U.S. Stocks Pulling Back Sharply Amid Renewed Tech Sector Weakness

India, Oct. 22 -- Stocks have moved sharply lower during trading on Thursday, giving back ground after trending higher over the past few sessions. The tech-heavy Nasdaq is posting a significant loss a... Read More


TTM Technologies Stock Plunges 26% Despite Higher Q3 Earnings And Revenue

India, Oct. 22 -- TTM Technologies, Inc. (TTMI) is down 25.85 percent, losing $26.41 to $75.74 on Thursday. The decline comes despite the company reporting higher third-quarter earnings and revenue. N... Read More


Lam Research Stock Falls 9%

India, Oct. 22 -- Lam Research Corporation (LRCX) is down 8.95 percent, losing $23.35 to $237.46 on Thursday. The decline comes despite the company reporting higher third-quarter earnings and revenue ... Read More


Spotify Stock Jumps 9% As Q3 Revenue Rises Despite Lower Profit

India, Oct. 22 -- Spotify Technology S.A. (SPOT) is up 8.85 percent, gaining $46.51 to $571.85 on Thursday. The rise follows the company's third-quarter results, with revenue increasing 16.3 percent e... Read More


Arcus Biosciences Prices $250 Mln Public Offering At $17.50/Share

India, Oct. 22 -- Arcus Biosciences, Inc. (RCUS), a late-stage biopharmaceutical company developing treatments for cancer and immune diseases, on Wednesday priced a public offering of 14.28 million co... Read More


Sagimet Biosciences Begins Pivotal Phase 3 Study Of Denifanstat In Acne Patients

India, Oct. 22 -- Sagimet Biosciences (SGMT) announced that the first patient has been dosed in AURORA, its pivotal U.S. Phase 3 clinical trial evaluating denifanstat for moderate to severe acne in ad... Read More


U.S. Leading Economic Index Unexpectedly Unchanged In September

India, Oct. 22 -- The Conference Board released a report on Thursday showing its reading leading U.S. economic indicators unexpectedly came in flat in the month of September. The report said the lead... Read More